![]() |
|
|
Vol. 296, Issue 2, 573-583, February 2001
Institute of Pharmacology and Toxicology, Consejo Superior de
Investigaciones Científicas, School of Medicine, Universidad
Complutense, Madrid, Spain
We have studied and compared the effects of bupivacaine with those
induced by a new local anesthetic, IQB-9302, on human cardiac K+ channels hKv1.5, Kv2.1, Kv4.3, and HERG.
Both drugs have a close chemical structure, only differing in their
N-substituent (n-butyl and cyclopropylmethyl, for
bupivacaine and IQB-9302, respectively). Both drugs blocked Kv2.1,
Kv4.3, and HERG channels similarly. Bupivacaine
inhibited these channels by 48.6 ± 3.4, 45.4 ± 12.4, and
43.1 ± 9.1%, respectively, and IQB-9302 by 48.1 ± 3.3, 36.1 ± 3.7, and 50.3 ± 6.6%, respectively. However,
bupivacaine was 2.5 times more potent than IQB-9302 to block hKv1.5
channels (EC50 = 8.9 ± 1.4 versus 21.5 ± 4.7 µM). Both drugs induced a time- and voltage-dependent block of
hKv1.5 and Kv2.1 channels. Block of Kv4.3 channels induced by either
drug was time- and voltage-dependent at membrane potentials coinciding
with the activation of the channels. IQB-9302 produced an instantaneous
block of Kv4.3 and hKv1.5 channels at the beginning of the depolarizing
pulse that can be interpreted as a drug interaction with a
nonconducting state. Bupivacaine and IQB-9302 induced a similar degree
of block of HERG channels and induced a steep
voltage-dependent decrease of the relative current. These results
suggest that 1) bupivacaine and IQB-9302 block the open state of
hKv1.5, Kv2.1, Kv4.3, and HERG channels; and 2) small
differences at the N-substituent of these drugs do not affect the
drug-induced block of Kv2.1, Kv4.3, or HERG, but specifically modify block of hKv1.5 channels.
This article has been cited by other articles:
![]() |
J. Nilsson, M. Madeja, F. Elinder, and P. Arhem Bupivacaine Blocks N-Type Inactivating Kv Channels in the Open State: No Allosteric Effect on Inactivation Kinetics Biophys. J., December 1, 2008; 95(11): 5138 - 5152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Felleiter, P. Lierz, and J. Graf The Effects of Local Anesthetics on Bile Flow, Potassium Equilibrium and Oxygen Consumption in the Perfused Rat Liver Anesth. Analg., February 1, 2006; 102(2): 473 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yun Cho, E. A. Beckett, S. A. Baker, I. Han, K. J. Park, K. Monaghan, S. M. Ward, K. M. Sanders, and S. D. Koh A pH-sensitive potassium conductance (TASK) and its function in the murine gastrointestinal tract J. Physiol., May 15, 2005; 565(1): 243 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Friederich, A. Solth, S. Schillemeit, and D. Isbrandt Local anaesthetic sensitivities of cloned HERG channels from human heart: comparison with HERG/MiRP1 and HERG/MiRP1T8A Br. J. Anaesth., January 1, 2004; 92(1): 93 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Kindler, M. Paul, H. Zou, C. Liu, B. D. Winegar, A. T. Gray, and C. S. Yost Amide Local Anesthetics Potently Inhibit the Human Tandem Pore Domain Background K+ Channel TASK-2 (KCNK5) J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 84 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gonzalez, R. Navarro-Polanco, C. Arias, R. Caballero, I. Moreno, E. Delpon, J. Tamargo, M. M. Tamkun, and C. Valenzuela Assembly with the Kvbeta 1.3 Subunit Modulates Drug Block of hKv1.5 Channels Mol. Pharmacol., December 1, 2002; 62(6): 1456 - 1463. [Abstract] [Full Text] [PDF] |
||||